Suppr超能文献

肾脏疾病中的坏死性炎症

Necroinflammation in Kidney Disease.

作者信息

Mulay Shrikant R, Linkermann Andreas, Anders Hans-Joachim

机构信息

Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany; and.

Clinic for Nephrology and Hypertension, Christian-Albrechts-University Kiel, Kiel, Germany.

出版信息

J Am Soc Nephrol. 2016 Jan;27(1):27-39. doi: 10.1681/ASN.2015040405. Epub 2015 Sep 2.

Abstract

The bidirectional causality between kidney injury and inflammation remains an area of unexpected discoveries. The last decade unraveled the molecular mechanisms of sterile inflammation, which established danger signaling via pattern recognition receptors as a new concept of kidney injury-related inflammation. In contrast, renal cell necrosis remained considered a passive process executed either by the complement-related membrane attack complex, exotoxins, or cytotoxic T cells. Accumulating data now suggest that renal cell necrosis is a genetically determined and regulated process involving specific outside-in signaling pathways. These findings support a unifying theory in which kidney injury and inflammation are reciprocally enhanced in an autoamplification loop, referred to here as necroinflammation. This integrated concept is of potential clinical importance because it offers numerous innovative molecular targets for limiting kidney injury by blocking cell death, inflammation, or both. Here, the contribution of necroinflammation to AKI is discussed in thrombotic microangiopathies, necrotizing and crescentic GN, acute tubular necrosis, and infective pyelonephritis or sepsis. Potential new avenues are further discussed for abrogating necroinflammation-related kidney injury, and questions and strategies are listed for further exploration in this evolving field.

摘要

肾损伤与炎症之间的双向因果关系仍是一个充满意外发现的领域。过去十年揭示了无菌性炎症的分子机制,该机制通过模式识别受体建立危险信号,成为肾损伤相关炎症的一个新概念。相比之下,肾细胞坏死仍被认为是一个由补体相关膜攻击复合物、外毒素或细胞毒性T细胞执行的被动过程。现在越来越多的数据表明,肾细胞坏死是一个涉及特定外向内信号通路的基因决定和调控的过程。这些发现支持了一种统一理论,即肾损伤和炎症在一个自我放大循环中相互增强,在此称为坏死性炎症。这个综合概念具有潜在的临床重要性,因为它提供了许多通过阻断细胞死亡、炎症或两者来限制肾损伤的创新分子靶点。在此,将在血栓性微血管病、坏死性和新月形肾小球肾炎、急性肾小管坏死以及感染性肾盂肾炎或脓毒症中讨论坏死性炎症对急性肾损伤的影响。还将进一步讨论消除坏死性炎症相关肾损伤的潜在新途径,并列出在这个不断发展的领域中进一步探索的问题和策略。

相似文献

1
Necroinflammation in Kidney Disease.
J Am Soc Nephrol. 2016 Jan;27(1):27-39. doi: 10.1681/ASN.2015040405. Epub 2015 Sep 2.
2
Cell Death Pathways Drive Necroinflammation during Acute Kidney Injury.
Nephron. 2018;140(2):144-147. doi: 10.1159/000490807. Epub 2018 Jun 29.
3
How Kidney Cell Death Induces Renal Necroinflammation.
Semin Nephrol. 2016 May;36(3):162-73. doi: 10.1016/j.semnephrol.2016.03.004.
4
Extracellular traps in kidney disease.
Kidney Int. 2018 Dec;94(6):1087-1098. doi: 10.1016/j.kint.2018.08.035.
7
Assessment of KDIGO definitions in patients with histopathologic evidence of acute renal disease.
Clin J Am Soc Nephrol. 2014 Jul;9(7):1175-82. doi: 10.2215/CJN.06150613. Epub 2014 May 1.
8
Necroptosis in Acute Kidney Injury.
Nephron. 2018;139(4):342-348. doi: 10.1159/000489940. Epub 2018 May 31.
9
Donor kidney injury molecule-1 promotes graft recovery by regulating systemic necroinflammation.
Am J Transplant. 2018 Aug;18(8):2021-2028. doi: 10.1111/ajt.14745. Epub 2018 Apr 20.
10
ADAMTS13 protects mice against renal ischemia-reperfusion injury by reducing inflammation and improving endothelial function.
Am J Physiol Renal Physiol. 2019 Jan 1;316(1):F134-F145. doi: 10.1152/ajprenal.00405.2018. Epub 2018 Nov 21.

引用本文的文献

1
The role of ferroptosis in acute kidney injury: the preemptive mode of cell death and the bridging effect.
Ren Fail. 2025 Dec;47(1):2536732. doi: 10.1080/0886022X.2025.2536732. Epub 2025 Aug 29.
4
Neutrophils and NETs in kidney disease.
Nat Rev Nephrol. 2025 Mar 18. doi: 10.1038/s41581-025-00944-3.
5
Regeneration following tissue necrosis is mediated by non-apoptotic caspase activity.
Elife. 2025 Mar 5;13:RP101114. doi: 10.7554/eLife.101114.
6
Targeting Hsp90α to inhibit HMGB1-mediated renal inflammation and fibrosis.
Cell Prolif. 2025 Mar;58(3):e13774. doi: 10.1111/cpr.13774. Epub 2024 Nov 20.
7
The Controversial Role of Glucocorticoids in Atheroembolic Renal Disease: A Narrative Review.
J Clin Med. 2024 Oct 27;13(21):6441. doi: 10.3390/jcm13216441.
8
Regeneration following tissue necrosis is mediated by non-apoptotic caspase activity.
bioRxiv. 2024 Dec 20:2024.07.26.605350. doi: 10.1101/2024.07.26.605350.
10

本文引用的文献

1
Regulation of tumour necrosis factor signalling: live or let die.
Nat Rev Immunol. 2015 Jun;15(6):362-74. doi: 10.1038/nri3834.
2
Eculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS.
Blood. 2015 May 21;125(21):3253-62. doi: 10.1182/blood-2014-09-600411. Epub 2015 Apr 1.
3
Take my breath away: necrosis in kidney transplants kills the lungs!
Kidney Int. 2015 Apr;87(4):680-2. doi: 10.1038/ki.2015.13.
4
Structure guided design of potent and selective ponatinib-based hybrid inhibitors for RIPK1.
Cell Rep. 2015 Mar 24;10(11):1850-60. doi: 10.1016/j.celrep.2015.02.052.
5
Ferroptosis as a p53-mediated activity during tumour suppression.
Nature. 2015 Apr 2;520(7545):57-62. doi: 10.1038/nature14344. Epub 2015 Mar 18.
7
A Role for Tubular Necroptosis in Cisplatin-Induced AKI.
J Am Soc Nephrol. 2015 Nov;26(11):2647-58. doi: 10.1681/ASN.2014080741. Epub 2015 Mar 18.
8
Ppm1b negatively regulates necroptosis through dephosphorylating Rip3.
Nat Cell Biol. 2015 Apr;17(4):434-44. doi: 10.1038/ncb3120. Epub 2015 Mar 9.
9
HSPB1 as a novel regulator of ferroptotic cancer cell death.
Oncogene. 2015 Nov 5;34(45):5617-25. doi: 10.1038/onc.2015.32. Epub 2015 Mar 2.
10
The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease.
Nat Med. 2015 Mar;21(3):263-9. doi: 10.1038/nm.3804. Epub 2015 Feb 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验